Shan Dong Kexing Bioproducts Co.,Ltd. Posted 49.9 Million Yuan Net Loss in First Half of 2023

Shan Dong Kexing Bioproducts Co.,Ltd. (科兴生物制药股份有限公司) (688136.SH) reported a net loss of 49.9 million yuan in the first half of 2023, reversing a net profit of 2.5 million yuan for the same period in the previous year.

Meanwhile, the company posted 649 million yuan in revenue, up 3.1% year-on-year.

At the end of the reporting period, it had 3.2 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 45.1%.